MANAGEMENT OF DEPRESSION IN ADOLESCENTS WITH HOMOEOPATHY

MANAGEMENT OF DEPRESSION IN ADOLESCENTS WITH HOMOEOPATHIC INTERVENTION- A PROSPECTIVE,SINGLE-ARM, OPEN-LABEL, INTERVENTIONAL STUDY - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084427

Enrollment

Registered

2025-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders

Interventions

Intervention1: HOMOEOPATHIC MEDICINES: To Study the Effect of Homoeopathic medicine in the management of depression in Adolescents Control Intervention1: NOT APPLICABLE: NILL Control Intervention2: NO

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to the age group of 12-19 years. Cases fulfilling the criteria for MDD in ICD-10 Cases fulfilling scores of mild (5-9), moderate (10-14), and moderately severe (15-19), in the PHQ-9 • Subjects belonging to both sexes. • Written informed consent. (If the participant’s age is above 18 years Written informed consent will be obtained from the participant only and if the participant is below the age of 18 years Written informed consent will be obtained from both participant and parents.)

Exclusion criteria

Exclusion criteria: Severe depression (greater than 20), in the PHQ-9 Patients taking anti-psychiatric drugs Any other pre-existing mental disorder. Presence of risk of suicide or self-destructive behaviours. Known cases of Tuberculosis, HIV, Cancer, etc.

Design outcomes

Primary

Measure	Time frame
OUTCOME MEASUREMENT -1 Title: Reduction in score PHQ-9 Description: Final value -5th month value- 4th month value-3rd month value -10th week value- 8th week value-6th week value-4th week value-2nd week value-baseline in PHQ-9. Interval: 2-week intervals for the first 3 months, then monthly once for the next 3 months. (Total 10 values) Timepoint: Interval: 2-week intervals for the first 3 months, then monthly once for the next 3 months. (Total 10 values)	—

Measure

Time frame

OUTCOME MEASUREMENT -1 Title: Reduction in score PHQ-9 Description: Final value -5th month value- 4th month value-3rd month value -10th week value- 8th week value-6th week value-4th week value-2nd week value-baseline in PHQ-9. Interval: 2-week intervals for the first 3 months, then monthly once for the next 3 months. (Total 10 values) Timepoint: Interval: 2-week intervals for the first 3 months, then monthly once for the next 3 months. (Total 10 values)

—

Secondary

Measure	Time frame
OUTCOME MEASUREMENT -2 Title: Improvement in WHOQOL-BREFF Description: Final value –baseline in WHOQOL-BREFF Interval: WHOQOL-BREFF – 6 months Timepoint: Interval: WHOQOL-BREFF – 6 months	—

Countries

India

Contacts

Public ContactDr MANU CHANDRAN K C

Department Of Practice of Medicine

lizmyajith@gmail.com09447551747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026